Donald Jensen to Drug Design
This is a "connection" page, showing publications Donald Jensen has written about Drug Design.
Connection Strength
0.702
-
Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C: design, development, and place in therapy. Drug Des Devel Ther. 2019; 13:2565-2577.
Score: 0.702